论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Shang X, Wang Z, Tao H
Received 17 April 2017
Accepted for publication 7 June 2017
Published 1 August 2017 Volume 2017:13 Pages 951—956
DOI https://doi.org/10.2147/TCRM.S139814
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Hoa Le
Peer reviewer comments 2
Editor who approved publication: Professor Deyun Wang
Abstract: Osteoarthritis (OA) is the most common form of articular joint arthritis
and a cause of significant morbidity. In this review, we present the role of
nerve growth factor (NGF) in pain generation, relationship between NGF and OA
pain, and pathogenic factors (interleukin-1β, transforming growth factor-β1,
mechanical loading, and adipokines) involved in OA development. Since NGF
blocking is an efficient way to inhibit OA-associated pain, we summarize four
categories of drugs that target NGF/tropomyosin receptor kinase A (TrkA)
signaling. In addition, we discuss the future of NGF/TrkA antagonists and
underline their potential for use in OA pain relief. A better understanding of
the causes and treatment of OA will facilitate the development of more
effective methods of OA pain management.
Keywords: osteoarthritis,
pain, nerve growth factor, TRPV1, TrkA